Women's Health News

RSS

Evaluating potential of Ampligen and TLR3 agonists as cancer immunotherapeutics

Hemispherx Biopharma, Inc., announced today the publication of an editorial entitled "TLR3 agonists as immunotherapeutic agents," published in the March 15, 2010 edition of Immunotherapy (2010) 2(2), 137-140, co-authored by Jonathan S. Berek, MD, Chairman, Stanford University School of Medicine Department of Obstetrics and Gynecology, and Christopher F. Nicodemus, MD, Chairman and Chief Scientific Officer, Advanced Immune Therapeutics, Inc., and HEB Consultant.

26 Mar 2010

Informing young women surviving breast cancer about opportunities to have children

At a time when more and more young women are surviving breast cancer and delaying childbirth, it is important to take their needs and wishes about their future fertility into consideration when deciding on treatment, the seventh European Breast Cancer Conference (EBCC7) in Barcelona will hear today.

26 Mar 2010

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research.

26 Mar 2010

Adjuvant systemic must be considered for treatment of primary breast cancer and recurrence

Recurrence of breast cancer in the same area as the original tumour remains the strongest, independent prognostic factor for subsequent metastasis and death, even for patients who have been free of disease for a very long time, according to research presented today (Wednesday) at the seventh European Breast Cancer Conference (EBCC7).

26 Mar 2010

Complex relation between breastfeeding, prolactin and breast cancer

Women who are diagnosed with breast cancer in the 12 months after they have completed a pregnancy are 48% more likely to die than other young women with breast cancer according to new research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).

26 Mar 2010

Pregnant breast cancer patients can receive chemotherapy without endangering baby health

Women who discover they have breast cancer while they are pregnant can be treated with chemotherapy without endangering the health of their unborn baby, according to research to be presented at the seventh European Breast Cancer Conference (EBCC7) in Barcelona today (Friday).

26 Mar 2010

Women continue to be main caregivers for minors, elderly, disabled and sick

The main conclusion of this research is that in spite of the noteworthy advances of recent decades, women continue to be the main caregivers for minors as well as for the elderly, disabled or the sick. In general, traditional family care is increasingly more unsustainable, chiefly because of women's incorporation into the workplace and the decrease in the number of housewives, the increase of the aging population, and the increasing age of the caregivers themselves.

26 Mar 2010

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Recently published research has shown that some breast cancer patients taking tamoxifen may not be getting the full benefit of their treatment because they have also been taking selective serotonin reuptake inhibitors, prescribed drugs that inhibit the effect of an important enzyme.

26 Mar 2010

Pregnancy safe for breast cancer survivors, says study

Women who have been treated for breast cancer can choose to become pregnant and have babies, without fears that pregnancy could put them at higher risk of dying from their cancer, according to a major, new study.

26 Mar 2010

Mexican-American women les likely to use emergency medical services for stroke symptoms

Mexican Americans are 40 percent less likely than non-Hispanic whites to call 9-1-1 and be taken to the hospital via ambulance for stroke - resulting in medical treatment delays - according to a new study reported in Stroke: Journal of the American Heart Association.

26 Mar 2010

Threats and vandalism against Democrats who vote for health reform

"The FBI is investigating acts of vandalism and a death threat aimed at Democrats who voted for the health care legislation." One incident involved Rep. Louise Slaughter, D-N.Y., "who had a prominent role in passing the historic legislation as chairwoman of the House Rules Committee, [and] said a window in a district office was shattered by a brick and a voicemail 'referencing snipers' was left on a campaign office phone."

26 Mar 2010

Obama's closed-door signing of executive order on abortion funding raises objections

President Barack Obama signed an executive order Wednesday pledging that no federal funding will be used for abortion under the new health bill.

26 Mar 2010

Cook Medical to feature its Goldstein SonoBiopsy Catheter at 2010 AIUM convention

With over 10 million women in the U.S. suffering from endometrial disorders like abnormal uterine bleeding or uterine fibroids, the 2010 American Institute of Ultrasound Medicine convention will feature specialized programs and product showcases highlighting imaging solutions available to better diagnose these conditions.

26 Mar 2010

New study: Egg donors may be paid too much

"Women who donate eggs for use with in-vitro techniques aren't supposed to be compensated more than $10,000 .... according to guidelines from the American Society of Reproductive Medicine," The Wall Street Journal reports.

26 Mar 2010

Human rights organization calls for national action to combat rising pregnancy-related complications

Amnesty International today pointed to new government figures showing the highest-ever rate of Caesarean sections as more evidence the United States needs to adopt guidelines for the use of obstetric procedures to begin reversing rising pregnancy complications and maternal deaths.

26 Mar 2010

Palex Medical to distribute Genomic Health's Oncotype DX breast cancer test in Spain and Portugal

Genomic Health, Inc. today announced that the company has entered into an exclusive agreement with Palex Medical S.A., one of Europe's leading distributors of medical device and diagnostic services to hospitals, to distribute its Oncotype DX® breast cancer test in Spain and Portugal. The distribution agreement, announced in conjunction with positive data presented today at the 7th European Breast Cancer Conference (EBCC), further expands the global presence of Oncotype DX, providing for increased physician and patient access to this advanced diagnostic test in the European market.

26 Mar 2010

Sexual abuse in childhood triggers retraumatization during pregnancy

A new study carried out by Prof. Rachel Lev-Wiesel and Dr. Tzachi Ben Zion has found that women who were victims of sexual abuse in childhood reported higher levels of depression and symptoms of post-trauma during pregnancy.

26 Mar 2010

Beaumont Hospital opens women's urology center

It’s something that women don’t talk about even to their best friends or their doctors. That’s why Beaumont Hospitals has created a new Women’s Urology Center offering leading-edge treatments, innovative research and the most advanced minimally invasive procedures for women’s urological conditions such as incontinence, pelvic pain and sexual dysfunction.

25 Mar 2010

Fertility industry offers big money to recruit “desirable” egg donors at top universities

Many egg donation agencies and private couples routinely exceed compensation recommendation limits for potential donors, a new study finds.

25 Mar 2010

$Osteoporosis drugs falsely implicated in rare thigh bone fractures, say new reports$

Osteoporosis drugs falsely implicated in rare thigh bone fractures, say new reports

Osteoporosis is a disease of the bones usually affecting elderly women and causes the bones to become brittle and easily breakable. Since last two years some alarming reports of women on drugs for therapy of this disease have come to notice. These reports show that these drugs intended for therapy may result in rare and serious fractures of their thigh bones where the bones break clean or may splinter. Often these fractures were not associated with any fall or impact. Moreover some of the sufferers are middle aged women in their 50’s who do not have full blown osteoporosis, a condition known as pre-osteoporosis or osteopenia.

25 Mar 2010

Women's Health News

Evaluating potential of Ampligen and TLR3 agonists as cancer immunotherapeutics

Informing young women surviving breast cancer about opportunities to have children

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Adjuvant systemic must be considered for treatment of primary breast cancer and recurrence

Complex relation between breastfeeding, prolactin and breast cancer

Pregnant breast cancer patients can receive chemotherapy without endangering baby health

Women continue to be main caregivers for minors, elderly, disabled and sick

Changing drug therapy can help breast cancer patients get full benefit of tamoxifen treatment

Pregnancy safe for breast cancer survivors, says study

Mexican-American women les likely to use emergency medical services for stroke symptoms

Threats and vandalism against Democrats who vote for health reform

Obama's closed-door signing of executive order on abortion funding raises objections

Cook Medical to feature its Goldstein SonoBiopsy Catheter at 2010 AIUM convention

New study: Egg donors may be paid too much

Human rights organization calls for national action to combat rising pregnancy-related complications

Palex Medical to distribute Genomic Health's Oncotype DX breast cancer test in Spain and Portugal

Sexual abuse in childhood triggers retraumatization during pregnancy

Beaumont Hospital opens women's urology center

Fertility industry offers big money to recruit “desirable” egg donors at top universities

Osteoporosis drugs falsely implicated in rare thigh bone fractures, say new reports

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Latest News